Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
PHASE4
The primary objective was to demonstrate a difference between two insulin s...
Status
Completed
Location
For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-651-4559), Monday-Friday, 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician
Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
NA
Сomparative pharmacokinetic study of Rinsulin® NPH, suspension for subcutan...
A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus
PHASE4
The purpose of the study is to compare the effects on overall glycaemic con...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.